The DOI matches its Crossref record; 770 of the 770 references it cites were found in a registry or an index.
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
Open accessAbstract
Virus-like particle (VLP) technology is a promising approach for the construction of novel vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived from non-enveloped icosahedral or helical viruses and proved to be viable vaccine candidates due to their effective presentation of epitopes in a native conformation. VLP technology has also been used to prepare chimeric VLPs decorated with genetically fused or chemically coupled epitope stretches selected from immunologically defined target proteins. However, structural constraints associated with the rigid geometrical architecture of icosahedral or helical VLPs pose challenges for the expression and presentation of large epitopes. Complex VLPs derived from non-symmetric enveloped viruses are increasingly being used to incorporate large epitopes and even full-length foreign proteins. Pleomorphic VLPs derived from influenza or other enveloped viruses can accommodate multiple full-length and/or chimeric proteins that can be rationally designed for multifunctional purposes, including multivalent vaccines. Therefore, a second generation of VLP carriers is represented by complex particles reconstructed from natural or chimeric structural proteins derived from complex enveloped viruses. Further development of safe and efficient VLP nanotechnology may require a rational combination of both approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Urisman, A., Molinaro, R. J., Fischer, N., Plummer, S. J., Casey, G., Klein, E. A., Malathi, K., Magi-Galluzzi, C., Tubbs, R. R., Ganem, D., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020025 · Cited by 577
RetractedBradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,843
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
[6] Use of T7 RNA polymerase to direct expression of cloned genes
William Studier, F., Rosenberg, A. H., Dunn, J. J., & Dubendorff, J. W. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)85008-c · Cited by 6,562
Cited by
Items 201–300 of 321
Japanese encephalitis: The virus and vaccines
Yun, S.-I., & Lee, Y.-M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26902 · Cited by 288
Dempsey, A. F., Pyrznawoski, J., Lockhart, S., Barnard, J., Campagna, E. J., Garrett, K., Fisher, A., Dickinson, L. M., & O’Leary, S. T. (2018) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2018.0016 · Cited by 288
Influenza Virus Matrix Protein Is the Major Driving Force in Virus Budding
Gómez-Puertas, P., Albo, C., Pérez-Pastrana, E., Vivo, A., & Portela, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11538-11547.2000 · Cited by 287
Bartenschlager, R., Junker-Niepmann, M., & Schaller, H. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5324-5332.1990 · Cited by 285
Galibert, F., Chen, T. N., & Mandart, E. (1982) · Journal of Virology · doi:10.1128/jvi.41.1.51-65.1982 · Cited by 284
How will HPV vaccines affect cervical cancer?
Roden, R., & Wu, T.-C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1973 · Cited by 283
Mechanisms for enveloped virus budding: Can some viruses do without an ESCRT?
Chen, B. J., & Lamb, R. A. (2008) · Virology · doi:10.1016/j.virol.2007.11.008 · Cited by 283
Multiple origins of viral capsid proteins from cellular ancestors
Krupovic, M., & Koonin, E. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621061114 · Cited by 282
Elton, D., Simpson-Holley, M., Archer, K., Medcalf, L., Hallam, R., McCauley, J., & Digard, P. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.408-419.2001 · Cited by 281
Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination
Bruun, T. U. J., Andersson, A.-M. C., Draper, S. J., & Howarth, M. (2018) · ACS Nano · doi:10.1021/acsnano.8b02805 · Cited by 281
Different Heparan Sulfate Proteoglycans Serve asCellular Receptors for HumanPapillomaviruses
Shafti-Keramat, S., Handisurya, A., Kriehuber, E., Meneguzzi, G., Slupetzky, K., & Kirnbauer, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13125-13135.2003 · Cited by 279
Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., & Burton, D. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1252-1261.2005 · Cited by 278
Chappell, J. D. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.1 · Cited by 278
Emerging role of natural products in cancer immunotherapy
Dong, S., Guo, X., Han, F., He, Z., & Wang, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.020 · Cited by 278
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Pollet, J., Chen, W.-H., & Strych, U. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.001 · Cited by 277
Microbial Nano-Factories: Synthesis and Biomedical Applications
Ghosh, S., Ahmad, R., Zeyaullah, M., & Khare, S. K. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.626834 · Cited by 277
Opalka, D., Lachman, C. E., MacMullen, S. A., Jansen, K. U., Smith, J. F., Chirmule, N., & Esser, M. T. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.108-115.2003 · Cited by 276
Roden, R. B., Greenstone, H. L., Kirnbauer, R., Booy, F. P., Jessie, J., Lowy, D. R., & Schiller, J. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5875-5883.1996 · Cited by 275
VSIG4, a B7 family-related protein, is a negative regulator of T cell activation
Vogt, L., Schmitz, N., Kurrer, M. O., Bauer, M., Hinton, H. I., Behnke, S., Gatto, D., Sebbel, P., Beerli, R. R., Sonderegger, I., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25673 · Cited by 272
Landau, N. R., Page, K. A., & Littman, D. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.162-169.1991 · Cited by 271
Hurley, J. H., Boura, E., Carlson, L.-A., & Różycki, B. (2010) · Cell · doi:10.1016/j.cell.2010.11.030 · Cited by 271
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity · doi:10.1155/2016/8501693 · Cited by 270
Conserved and host-specific features of influenza virion architecture
Hutchinson, E. C., Charles, P. D., Hester, S. S., Thomas, B., Trudgian, D., Martínez-Alonso, M., & Fodor, E. (2014) · Nature Communications · doi:10.1038/ncomms5816 · Cited by 269
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
Boscardin, S. B., Hafalla, J. C. R., Masilamani, R. F., Kamphorst, A. O., Zebroski, H. A., Rai, U., Morrot, A., Zavala, F., Steinman, R. M., Nussenzweig, R. S., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051639 · Cited by 269
Shi, S. T., Lee, K.-J., Aizaki, H., Hwang, S. B., & Lai, M. M. C. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4160-4168.2003 · Cited by 268
A human hepatitis B viral enhancer element.
Shaul, Y., Rutter, W. J., & Laub, O. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03646.x · Cited by 267
The Art of Engineering Viral Nanoparticles
Pokorski, J. K., & Steinmetz, N. F. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100225y · Cited by 266
Display technologies: Application for the discovery of drug and gene delivery agents☆
SERGEEVA, A., KOLONIN, M., MOLLDREM, J., PASQUALINI, R., & ARAP, W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.018 · Cited by 266
Molecular imaging with nanoparticles: giant roles for dwarf actors
Debbage, P., & Jaschke, W. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0511-y · Cited by 264
Felberbaum, R. S. (2015) · Biotechnology Journal · doi:10.1002/biot.201400438 · Cited by 264
Kuklin, N. A., Clark, D. J., Secore, S., Cook, J., Cope, L. D., McNeely, T., Noble, L., Brown, M. J., Zorman, J. K., Wang, X. M., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.4.2215-2223.2006 · Cited by 264
Tregoning, J. S., Russell, R. F., & Kinnear, E. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1415684 · Cited by 263
Nanotechnology for angiogenesis: opportunities and challenges
Kargozar, S., Baino, F., Hamzehlou, S., Hamblin, M. R., & Mozafari, M. (2020) · Chemical Society Reviews · doi:10.1039/c8cs01021h · Cited by 262
Shedding of norovirus in symptomatic and asymptomatic infections
TEUNIS, P. F. M., SUKHRIE, F. H. A., VENNEMA, H., BOGERMAN, J., BEERSMA, M. F. C., & KOOPMANS, M. P. G. (2015) · Epidemiology and Infection · doi:10.1017/s095026881400274x · Cited by 261
Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
Ho, W., Gao, M., Li, F., Li, Z., Zhang, X., & Xu, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001812 · Cited by 261
Phosphorylation-dependent Binding of Hepatitis B Virus Core Particles to the Nuclear Pore Complex
Kann, M., Sodeik, B., Vlachou, A., Gerlich, W. H., & Helenius, A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.1.45 · Cited by 260
Rehermann, B., Chang, K. M., McHutchinson, J., Kokka, R., Houghton, M., Rice, C. M., & Chisari, F. V. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7092-7102.1996 · Cited by 260
Virus‐Based Chemical and Biological Sensing
Mao, C., Liu, A., & Cao, B. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900231 · Cited by 260
Immunomodulatory spherical nucleic acids
Radovic-Moreno, A. F., Chernyak, N., Mader, C. C., Nallagatla, S., Kang, R. S., Hao, L., Walker, D. A., Halo, T. L., Merkel, T. J., Rische, C. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502850112 · Cited by 259
Viral nanoparticles as platforms for next-generation therapeutics and imaging devices
Steinmetz, N. F. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.04.005 · Cited by 259
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
Pandya, P. H., Murray, M. E., Pollok, K. E., & Renbarger, J. L. (2016) · Journal of Immunology Research · doi:10.1155/2016/4273943 · Cited by 259
Extracellular vesicles as a platform for membrane‐associated therapeutic protein delivery
Yang, Y., Hong, Y., Cho, E., Kim, G. B., & Kim, I. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1440131 · Cited by 258
Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
Shanmugaraj, B., I. Bulaon, C. J., & Phoolcharoen, W. (2020) · Plants · doi:10.3390/plants9070842 · Cited by 257
Hirth, J. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1512453 · Cited by 256
Scientific barriers to developing vaccines against avian influenza viruses
Subbarao, K., & Joseph, T. (2007) · Nature Reviews Immunology · doi:10.1038/nri2054 · Cited by 255
Effect of vaccine administration modality on immunogenicity and efficacy
Zhang, L., Wang, W., & Wang, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1081067 · Cited by 255
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Bok, K., Sitar, S., Graham, B. S., & Mascola, J. R. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.017 · Cited by 254
Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo
Singh, P., Prasuhn, D., Yeh, R. M., Destito, G., Rae, C. S., Osborn, K., Finn, M. G., & Manchester, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.003 · Cited by 254
Garland, M., Yim, J. J., & Bogyo, M. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2015.12.003 · Cited by 254
The Potential for Microalgae as Bioreactors to Produce Pharmaceuticals
Yan, N., Fan, C., Chen, Y., & Hu, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060962 · Cited by 254
Controlling timing and location in vaccines
Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 254
Nanoparticle-Based Delivery Systems for Vaccines
Bezbaruah, R., Chavda, V. P., Nongrang, L., Alom, S., Deka, K., Kalita, T., Ali, F., Bhattacharjee, B., & Vora, L. (2022) · Vaccines · doi:10.3390/vaccines10111946 · Cited by 253
Yaginuma, K., Shirakata, Y., Kobayashi, M., & Koike, K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2678 · Cited by 253
Zhou, J., Liu, W. J., Peng, S. W., Sun, X. Y., & Frazer, I. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4972-4982.1999 · Cited by 253
Tumpey, T. M., Renshaw, M., Clements, J. D., & Katz, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5141-5150.2001 · Cited by 253
Engineering protein nanocages as carriers for biomedical applications
Bhaskar, S., & Lim, S. (2017) · NPG Asia Materials · doi:10.1038/am.2016.128 · Cited by 253
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Collins, K. A., Snaith, R., Cottingham, M. G., Gilbert, S. C., & Hill, A. V. S. (2017) · Scientific Reports · doi:10.1038/srep46621 · Cited by 253
Murakami, T., & Freed, E. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.343 · Cited by 252
Sankaranarayanan, R., Prabhu, P. R., Pawlita, M., Gheit, T., Bhatla, N., Muwonge, R., Nene, B. M., Esmy, P. O., Joshi, S., Poli, U. R. R., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00414-3 · Cited by 242
Graham, B. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00972.x · Cited by 239
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
Mroz, P. A., Finan, B., Gelfanov, V., Yang, B., Tschöp, M. H., DiMarchi, R. D., & Perez-Tilve, D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.001 · Cited by 229
Structural insight into the unique properties of adeno-associated virus serotype 9
DiMattia, M. A., Nam, H.-J., Van Vliet, K., Mitchell, M., Bennett, A., Gurda, B. L., McKenna, R., Olson, N. H., Sinkovits, R. S., Potter, M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07232-11 · Cited by 219
Mayer, D., Molawi, K., Martínez-Sobrido, L., Ghanem, A., Thomas, S., Baginsky, S., Grossmann, J., García-Sastre, A., & Schwemmle, M. (2007) · Journal of Proteome Research · doi:10.1021/pr060432u · Cited by 216
A comprehensive atlas of immunological differences between humans, mice, and non-human primates
Bjornson-Hooper, Z. B., Fragiadakis, G. K., Spitzer, M. H., Chen, H., Madhireddy, D., Hu, K., Lundsten, K., McIlwain, D. R., & Nolan, G. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867015 · Cited by 215
Enterovirus 71 infection and vaccines
Yi, E.-J., Shin, Y.-J., Kim, J.-H., Kim, T.-G., & Chang, S.-Y. (2017) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2017.6.1.4 · Cited by 203
Genetically modified plants and human health
Key, S., Ma, J. K.-C., & Drake, P. M. (2008) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.070372 · Cited by 197
Tang, R., Kim, C. S., Solfiell, D. J., Rana, S., Mout, R., Velázquez-Delgado, E. M., Chompoosor, A., Jeong, Y., Yan, B., Zhu, Z.-J., et al. (2013) · ACS Nano · doi:10.1021/nn402753y · Cited by 188
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Cid, R., & Bolívar, J. (2021) · Biomolecules · doi:10.3390/biom11081072 · Cited by 176
Snijder, J., van de Waterbeemd, M., Damoc, E., Denisov, E., Grinfeld, D., Bennett, A., Agbandje-McKenna, M., Makarov, A., & Heck, A. J. R. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502616y · Cited by 168
Marburg virus disease: a summary for clinicians
Kortepeter, M. G., Dierberg, K., Shenoy, E. S., & Cieslak, T. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.042 · Cited by 160
Binding of Rabbit Hemorrhagic Disease Virus to Antigens of the ABH Histo-Blood Group Family
Ruvoën-Clouet, N., Ganière, J. P., André-Fontaine, G., Blanchard, D., & Le Pendu, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11950-11954.2000 · Cited by 160
Brazzoli, M., Magini, D., Bonci, A., Buccato, S., Giovani, C., Kratzer, R., Zurli, V., Mangiavacchi, S., Casini, D., Brito, L. M., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01786-15 · Cited by 154
Rajasekhar, K., & Govindaraju, T. (2018) · RSC Advances · doi:10.1039/c8ra03620a · Cited by 150
Novel approaches for the design, delivery and administration of vaccine technologies
Wallis, J., Shenton, D. P., & Carlisle, R. C. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13287 · Cited by 123
Lopez Lopez, C., Tariot, P. N., Caputo, A., Langbaum, J. B., Liu, F., Riviere, M., Langlois, C., Rouzade‐Dominguez, M., Zalesak, M., Hendrix, S., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.02.005 · Cited by 116
Application of built-in adjuvants for epitope-based vaccines
Lei, Y., Zhao, F., Shao, J., Li, Y., Li, S., Chang, H., & Zhang, Y. (2019) · PeerJ · doi:10.7717/peerj.6185 · Cited by 115
Adeno-Associated Virus Structural Biology as a Tool in Vector Development
Drouin, L. M., & Agbandje-McKenna, M. (2013) · Future Virology · doi:10.2217/fvl.13.112 · Cited by 114
Roth, M. G., Fitzpatrick, J. P., & Compans, R. W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6430 · Cited by 112
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
Tsai, T. F. (2013) · Infection & Chemotherapy · doi:10.3947/ic.2013.45.2.159 · Cited by 107
Dimeric RNA Recognition Regulates HIV-1 Genome Packaging
Nikolaitchik, O. A., Dilley, K. A., Fu, W., Gorelick, R. J., Tai, S.-H. S., Soheilian, F., Ptak, R. G., Nagashima, K., Pathak, V. K., & Hu, W.-S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003249 · Cited by 106
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Zhang, F., Zhong, R.-J., Cheng, C., Li, S., & Le, W.-D. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00565-5 · Cited by 105
Peptides for Vaccine Development
Hamley, I. W. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01238 · Cited by 104
Bonnet, B., Messaoudi, K., Jacomet, F., Michaud, E., Fauquert, J. L., Caillaud, D., & Evrard, B. (2018) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-018-0239-8 · Cited by 96
Incretins in obesity and diabetes
Chia, C. W., & Egan, J. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14211 · Cited by 93
Li, M., Guan, Y., Zhao, A., Ren, J., & Qu, X. (2017) · Theranostics · doi:10.7150/thno.18459 · Cited by 90
Scholtzova, H., Do, E., Dhakal, S., Sun, Y., Liu, S., Mehta, P. D., & Wisniewski, T. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1967-16.2016 · Cited by 82
Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier
Albright, B. H., Storey, C. M., Murlidharan, G., Castellanos Rivera, R. M., Berry, G. E., Madigan, V. J., & Asokan, A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.10.017 · Cited by 82
Moreira, D., Adamus, T., Zhao, X., Su, Y.-L., Zhang, Z., White, S. V., Swiderski, P., Lu, X., DePinho, R. A., Pal, S. K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1277 · Cited by 80
Kinetic Modeling of Virus Growth in Cells
Yin, J., & Redovich, J. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00066-17 · Cited by 74
Cruising the cellular highways: how human papillomavirus travels from the surface to the nucleus
DiGiuseppe, S., Bienkowska-Haba, M., Guion, L. G., & Sapp, M. (2017) · Virus Research · doi:10.1016/j.virusres.2016.10.015 · Cited by 67
Golding, H., Khurana, S., & Zaitseva, M. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028902 · Cited by 67
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66
Lucien, F., Pelletier, P.-P., Lavoie, R. R., Lacroix, J.-M., Roy, S., Parent, J.-L., Arsenault, D., Harper, K., & Dubois, C. M. (2017) · Nature Communications · doi:10.1038/ncomms15884 · Cited by 66
A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles
Gómez, J. M. M., Fischer, S., Csaba, N., Kündig, T. M., Merkle, H. P., Gander, B., & Johansen, P. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9318-0 · Cited by 63
Targeting aging and age-related diseases with vaccines
Wu, R., Sun, F., Zhang, W., Ren, J., & Liu, G.-H. (2024) · Nature Aging · doi:10.1038/s43587-024-00597-0 · Cited by 66
Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18081115 · Cited by 56
Ren, D., Fisson, S., Dalkara, D., & Ail, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091973 · Cited by 52
Reverse transcriptase activity of an intron encoded polypeptide
Fassbender, S., Brühl, K. H., Ciriacy, M., & Kück, U. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06482.x · Cited by 52
Breaking Bottlenecks for the TCR Therapy of Cancer
Gaissmaier, L., Elshiaty, M., & Christopoulos, P. (2020) · Cells · doi:10.3390/cells9092095 · Cited by 52
Bahar, M. W., Porta, C., Fox, H., Macadam, A. J., Fry, E. E., & Stuart, D. I. (2021) · npj Vaccines · doi:10.1038/s41541-020-00267-3 · Cited by 42
Metadata
- Authors
- Pushko, P., Pumpens, P., & Grens, E.
- Venue
- Intervirology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 56
- Issue
- 3
- Pages
- 141-165
- ISSN
- 0300-5526 (ISSN-L)
- 1423-0100
- OpenAlex
- W2046182783
- Cited by
- 5,950
- References
- 770
- FWCI
- 295.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.